The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...
A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating ...
Based on phase 3 trial data, the FDA accepted an sBLA for nivolumab plus AVD for untreated stage III or IV classical Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback